These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2164112)
1. [The alpha subunits of the GTP-binding proteins, Go and Gi2 in lung cancer]. Ojika T; Imaizumi M; Abe T; Shimokata K; Asano T; Kato K Gan No Rinsho; 1990 Jul; 36(8):875-9. PubMed ID: 2164112 [TBL] [Abstract][Full Text] [Related]
2. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750 [TBL] [Abstract][Full Text] [Related]
4. Production of the alpha subunit of guanine nucleotide-binding protein GO by neuroendocrine tumors. Kato K; Asano T; Kamiya N; Haimoto H; Hosoda S; Nagasaka A; Ariyoshi Y; Ishiguro Y Cancer Res; 1987 Nov; 47(21):5800-5. PubMed ID: 2822234 [TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA. Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type]. Klech H; Rona G; Hutter C; Bayer PM; Kummer F Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion]. Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362 [TBL] [Abstract][Full Text] [Related]
8. [Tumor marker in lung cancer]. Shijubo N; Abe S Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790 [No Abstract] [Full Text] [Related]
9. [Evaluation of neuron-specific enolase as a new tumor marker for carcinoma of the lung]. Ariyoshi Y Gan No Rinsho; 1984 May; 30(6 Suppl):569-73. PubMed ID: 6086970 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer]. Fujii M; Kiura K; Kamei H; Segawa Y Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270 [No Abstract] [Full Text] [Related]
12. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer. Wu GP; Ba J; Zhao YJ; Wang EH Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156 [No Abstract] [Full Text] [Related]
13. [Serum neuron-specific enolase as a marker of lung cancers]. Fujisawa T; Yamaguchi Y; Sasaki K; Fukazawa T; Hongo H; Ogawa T; Kimura H Gan To Kagaku Ryoho; 1985 Jan; 12(1):139-43. PubMed ID: 2981514 [TBL] [Abstract][Full Text] [Related]
14. [Creatine kinase BB and neuron specific r-enolase as biomarkers for lung cancer]. Usui A; Fujita K; Imaizumi M; Abe T; Inoue K; Matsumoto S; Kato K Gan No Rinsho; 1987 Nov; 33(14):1763-70. PubMed ID: 2826840 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Nakanishi K; Hashizume S; Kato M; Honjoh T; Setoguchi Y; Yasumoto K Hum Antibodies; 1997; 8(4):189-94. PubMed ID: 9395921 [TBL] [Abstract][Full Text] [Related]
16. Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients. Schneider J; Peltri G; Bitterlich N; Philipp M; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Clin Exp Med; 2003 Feb; 2(4):185-91. PubMed ID: 12624710 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS; Cheng BC; Ge W; Gao JF Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612 [TBL] [Abstract][Full Text] [Related]
18. [Northern blot analysis of nm23 gene expression in human lung cancer]. Liu L; Qin Y; Zhou Q Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):342-4. PubMed ID: 10921026 [TBL] [Abstract][Full Text] [Related]
19. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]. Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891 [TBL] [Abstract][Full Text] [Related]
20. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase. Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]